Juravinski Cancer Center, Hamilton Health Sciences, Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada.
Curr Oncol. 2023 Feb 24;30(3):2743-2750. doi: 10.3390/curroncol30030207.
Healthcare systems in Canada and elsewhere have identified the need to develop methods to effectively and safely transition appropriate cancer survivors to primary care. It is generally accepted that survivors with a low risk of adverse events, including recurrence and toxicity, should be more systematically identified and offered transition. There remains a lack of clarity about what constitutes an appropriate profile that would assist greater application in practice. To address this gap, we examined the clinical profiles of patients that were transitioned from a large regional cancer centre to the community. The factors examined included disease site, clinical stage, time since diagnosis/first consult, cancer treatments, and Edmonton Symptom Assessment System (ESAS) scores. In total, 2604 patients were identified as transitioned between 2013 and 2020. These patients tended to have common cancers (e.g., breast, endometrium, colorectal) that were generally of lower stage. Half of the patients had received chemotherapy and/or radiation treatment. Nearly one-third of survivors were transitioned within a year of first consult and a third after five years. Most patients reported minimal symptoms based on ESAS scores prior to being transitioned. This study represents one of the first to analyze the types of cancer patients that are being selected for transition to primary care.
加拿大和其他国家的医疗保健系统已经认识到需要开发有效的方法,以安全地将合适的癌症幸存者过渡到初级保健。人们普遍认为,风险较低的幸存者,包括复发和毒性等不良事件,应更系统地识别并提供过渡服务。目前仍不清楚什么样的特征构成了适当的模式,这将有助于在实践中得到更广泛的应用。为了解决这一差距,我们研究了从大型区域癌症中心过渡到社区的患者的临床特征。检查的因素包括疾病部位、临床分期、诊断/首次就诊后的时间、癌症治疗和埃德蒙顿症状评估系统(ESAS)评分。总共确定了 2604 名在 2013 年至 2020 年间过渡的患者。这些患者往往患有常见的癌症(如乳腺癌、子宫内膜癌、结直肠癌),通常处于较低的阶段。一半的患者接受了化疗和/或放疗。近三分之一的幸存者在首次就诊后一年内,三分之一在五年后过渡。根据 ESAS 评分,大多数患者在过渡前报告的症状很少。这项研究是首次分析选择过渡到初级保健的癌症患者类型的研究之一。